Admission Date:  [**2192-8-15**]     Discharge Date:  [**2192-8-20**]  Date of Birth:   [**2138-6-1**]     Sex:  F  Service:  Surgery, Blue Team  HISTORY OF PRESENT ILLNESS:  The patient is a 54-year-old female who presents for elective gastric bypass procedure, Roux-en-Y, open cholecystectomy.
PAST SURGICAL HISTORY:  The patient had orthoscopic surgery of the right knee in [**2192-5-15**], pilonidal cyst removed in [**2158**], tubal ligation in [**2178**].
Advil 800 mg p.o.
Celexa 60 mg p.o.
Armour thyroid 120 mg p.o.
HOSPITAL COURSE:   The patient was admitted and underwent the indicated procedure of open Roux-en-Y gastric bypass with open cholecystectomy without complications.
Her Foley was irrigated with no increase in urine output.
The Foley was successfully placed early that morning at approximately 5 a.m., at which time no urine output was noted in the Foley bag.
Foley position was confirmed by a retrograde urethrogram.
A STAT set of blood was obtained which revealed a sodium of 138, potassium 5.2, chloride 101, bicarbonate 22, BUN of 27, creatinine of 3.1, glucose of 117.
At this time it was felt that a return to the operating room and re-exploration to rule out abdominal compartment syndrome and/or complications with surgery was warranted.
Renal consultation assessed the patient with the finding that the patient most likely suffered acute tubular necrosis secondary to multifactorial insult of taking large quantity of nonsteroidal antiinflammatory drugs (up to 800 mg of Advil q.i.d.
She was receiving Kefzol 1 g intravenous q.8.h., heparin 5000 units subcutaneous, Zantac 150 mg intravenously q.8.h., and a propofol drip to maintain a sedated status for the intubation.
Immediately postoperatively in the expiratory day, she had repeat laboratories which showed a sodium of 138, potassium of 5.2, and chloride of 101, bicarbonate of 22, BUN of 30, creatinine of 2.8 (down from 3.1), glucose of 117.
The patient was stable and intubated on synchronized intermittent mandatory ventilation.
postoperative day two from surgery and postoperative one for the re-exploration), the patient was in the Medical Intensive Care Unit and was stable overnight, and continued to make urine at approximately 30 cc to 40 cc an hour.
Of note, a gastric tube which had been placed in the second exploratory surgery to decompress the major gastric segment (i.e.
On the following day, [**2192-8-18**], the patient's nasogastric tube was discontinued and was advanced to a stage I diet.
On [**2192-8-19**], on postoperative days four/three, the patient continued to do well with ambulating, having tolerated a stage I diet was advanced to a stage II diet.
Patient-controlled analgesia was discontinued and switched to oral pain control with Roxicet with good effect.
The patient's preoperative medications were restarted.
Gastric bypass diet was reviewed, and plans were made for discharging the patient home.
Wound margins were clean, dry and intact and well approximated with no discharge, erythema, or exudate, or signs of infection.
DISCHARGE INSTRUCTIONS:  The patient was instructed on G-tube care and instruction.
The plan was made for the patient to keep the G-tube clamped; however, the patient was instructed to attach a Foley bag with which the patient will be discharged in case of feelings of excessive bloating, nausea or vomiting, and to call the Surgery Clinic if this happened.
Arrangements were made for visiting nurse to perform wound checks and G-tube checks for three days at home.
MEDICATIONS ON DISCHARGE:  (The was discharged with the medications as per outpatient and as follows) 1.
Celebrex 60 mg crushed p.o.
Vitamin B12 1000 mcg crushed p.o.
The patient's right internal jugular intravenous access was removed without complications.
A sterile dressing was applied, and Tegaderm placed over it.
Status post Roux-en-Y gastric bypass procedure.
